Avastin survival data mixed in breast cancer
In women with advanced breast cancer, progression-free survival(that is, a patient remaining alive without the disease gettingworse) is improved with the addition of Avastin to thecommonly-used drug paclitaxel, but overall survival is notaffected, according to a study reported in The New England Journalof Medicine this week.
More... |
All times are GMT -7. The time now is 07:59 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021